PMA

News PMA

• Genzyme Files for Approval of Single-Treatment Synvisc-One

  Genzyme Corp. announced that it has filed with the U.S. Food and Drug Administration (FDA) for approval of Synvisc-One(TM), the single treatment of Synvisc® (hylan G-F 20) that provides up to six months of pain relief from osteoarthritis (OA) of the knee. If approved, Synvisc-One would be the only v more

• Anika Therapeutics Announces Termination of Worldwide Development and Commercialization Partnership with OrthoNeutrogena

  Anika Therapeutics, Inc. announced that it has reached a mutual agreement with OrthoNeutrogena, a division of Ortho-McNeil Pharmaceuticals, for the termination of its development and commercialization contract for Anika's hyaluronic acid based cosmetic tissue augmentation (CTA) product, effective Au more

• Imaging Diagnostic Systems Installs Additional CTLM(R) System for Schering AG, Studies

  Fort Lauderdale. Imaging Diagnostic Systems, Inc. announced that Schering AG, Germany, has requested an additional CTLM(R) system as part of their collaborative efforts with IDSI to continue their studies of fluorescent compounds in their quest of breast cancer detection. Schering AG and Imaging Di more

Publications PMA

• Phosphorylation of CDK9 at Ser175 Enhances HIV Transcription and Is a Marker of Activated P-TEFb in CD4+ T Lymphocytes

  by Uri R. Mbonye, Giridharan Gokulrangan, Manish Datt, Curtis Dobrowolski, Maxwell Cooper, Mark R. Chance, Jonathan Karn The HIV transactivator protein, Tat, enhances HIV transcription by recruiting P-TEFb from the inactive 7SK snRNP complex and directing it to proviral elongation complexes. To t more

• Assessment of the Anti-invasion Potential and Mechanism of Select Cinnamic Acid Derivatives on Human Lung Adenocarcinoma Cells

  Patients with lung adenocarcinoma are often diagnosed with metastasizing symptoms and die of early and distal metastasis. Metastasis is made up of a cascade of interrelated and sequential steps, including cell adhesion, extracellular matrix degradation, cell movement, and invasion. Hence, substances more

• Protein kinase C activation causes neurite retraction via cyclinD1 and p60‐katanin increase in rat hippocampal neurons

  Abstract Neurons are differentiated postmitotic cells residing in G0 phase of the cell cycle and are unable to proceed through G1 phase, in which cyclinD1 needs to be up‐regulated for initiation. Yet, a growing body of evidence has shown that cell cycle re‐activation via cyclinD1 up‐regulation d more

Market studies PMA

• CLINICARE Corporation - Strategic SWOT Analysis Review

  CLINICARE Corporation (CLINICARE) is a healthcare IT company, which is engaged in the development, marketing and providing computerized information solutions for medical group practices principally in Canada. The company offers electronic medical records (EMR), practice management applications (PMA) more

• The Spectranetics Corporation (SPNC) - Financial and Strategic SWOT Analysis Review

  Spectranetics is engaged in the development, manufacture and marketing of single-use medical devices that are used in minimally invasive procedures in the cardiovascular system. The company produces laser sheath, lasers for vascular intervention, coronary laser ablation catheter, translucent shaft, more

Websites PMA